Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.64 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.64 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.58 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.58 |
| ▸ | CACNG2 | Q9Y698 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | PRKACA | P17612 | 1/20 | 0.48 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12205094 | 1.00 | ESR1 (0.64) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL10055038 | 1.00 | ESR1 (0.64) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL10047619 | 1.00 | ESR1 (0.64) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL13314068 | 0.98 | ESR1 (0.66) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL23097286 | 0.94 | ESR1 (0.58) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL22618148 | 0.94 | ESR2 (0.72) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL19238820 | 0.93 | ESR1 (0.56) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL12114860 | 0.93 | ESR2 (0.56) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL15835152 | 0.93 | ESR1 (0.59) | ESR1ESR2GRIA1CACNG8CACNG2 | |
| SCHEMBL12114718 | 0.93 | ESR2 (0.56) | ESR1ESR2GRIA1CACNG8CACNG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9853220-B2 | Efficient organic light-emitting diodes and fabrication of the same | NITTO DENKO CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-9853220-B2 | Efficient organic light-emitting diodes and fabrication of the same | NITTO DENKO CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| EP-2448925-B1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORP (JP) | 2017-12-06 | — | — | EP | disclosed |
| EP-2448925-B1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORP (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-20150041780-A1 | EFFICIENT ORGANIC LIGHT-EMITTING DIODES AND FABRICATION OF THE SAME | NITTO DENKO CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| US-20150041780-A1 | EFFICIENT ORGANIC LIGHT-EMITTING DIODES AND FABRICATION OF THE SAME | NITTO DENKO CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| US-8927121-B2 | Emissive aryl-heteroaryl compounds | NITTO DENKO CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| US-8927121-B2 | Emissive aryl-heteroaryl compounds | NITTO DENKO CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| US-8927121-B2 | Emissive aryl-heteroaryl compounds | NITTO DENKO CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| US-8771845-B2 | — | — | 2014-07-08 | — | — | US | disclosed |
| US-20120015998-A1 | PHOTOTHERAPY METHODS AND DEVICES COMPRISING EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20120015998-A1 | PHOTOTHERAPY METHODS AND DEVICES COMPRISING EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20120015998-A1 | PHOTOTHERAPY METHODS AND DEVICES COMPRISING EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| WO-2012009283-A1 | PHOTOTHERAPY METHODS AND DEVICES COMPRISING EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-19 | — | — | WO | disclosed |
| WO-2012009283-A1 | PHOTOTHERAPY METHODS AND DEVICES COMPRISING EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-19 | — | — | WO | disclosed |
| WO-2011008560-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2011-01-20 | — | — | WO | disclosed |
| WO-2011008560-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2011-01-20 | — | — | WO | disclosed |
| US-20100326526-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100326526-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100326526-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015998-A1 | PHOTOTHERAPY METHODS AND DEVICES COMPRISING EMISSIVE ARYL-HETEROARYL COMPOUNDS | ARNT, AHR, AR | ESR1 51/4885ESR2 14/4885GRIA1 581/4885 |
| US-20100326526-A1 | EMISSIVE ARYL-HETEROARYL COMPOUNDS | AHR, AR, ARNT | ESR1 43/4885ESR2 11/4885GRIA1 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.